×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SAVA – cassava sciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SAVA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/18
08:31 am
sava
Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer [Yahoo! Finance]
Low
Report
Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer [Yahoo! Finance]
11/18
08:30 am
sava
Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer
Low
Report
Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer
11/15
11:54 am
sava
Is Cassava Sciences (SAVA) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
Medium
Report
Is Cassava Sciences (SAVA) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
11/12
02:02 pm
sava
What Makes Cassava Sciences (SAVA) a New Buy Stock [Yahoo! Finance]
Low
Report
What Makes Cassava Sciences (SAVA) a New Buy Stock [Yahoo! Finance]
11/8
02:32 pm
sava
Cassava Sciences, Inc. (NASDAQ: SAVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $116.00 price target on the stock.
Medium
Report
Cassava Sciences, Inc. (NASDAQ: SAVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $116.00 price target on the stock.
11/7
08:08 am
sava
Cassava Sciences Reports Q3 2024 Financial and Operating Results [Yahoo! Finance]
Medium
Report
Cassava Sciences Reports Q3 2024 Financial and Operating Results [Yahoo! Finance]
11/7
07:55 am
sava
Cassava Sciences Reports Q3 2024 Financial and Operating Results
Medium
Report
Cassava Sciences Reports Q3 2024 Financial and Operating Results
10/31
08:30 am
sava
Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024
Low
Report
Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
11/20
04:39 pm
sava
Form 4 CASSAVA SCIENCES INC For: Nov 18 Filed by: Landen Jaren
High
Report
Form 4 CASSAVA SCIENCES INC For: Nov 18 Filed by: Landen Jaren
11/20
04:37 pm
sava
Form 3 CASSAVA SCIENCES INC For: Nov 18 Filed by: Landen Jaren
High
Report
Form 3 CASSAVA SCIENCES INC For: Nov 18 Filed by: Landen Jaren
11/20
04:35 pm
sava
Form 4 CASSAVA SCIENCES INC For: Nov 18 Filed by: Nassif Freda
High
Report
Form 4 CASSAVA SCIENCES INC For: Nov 18 Filed by: Nassif Freda
11/20
04:33 pm
sava
Form 3 CASSAVA SCIENCES INC For: Nov 18 Filed by: Nassif Freda
High
Report
Form 3 CASSAVA SCIENCES INC For: Nov 18 Filed by: Nassif Freda
11/7
04:33 pm
sava
Form 10-Q CASSAVA SCIENCES INC For: Sep 30
Medium
Report
Form 10-Q CASSAVA SCIENCES INC For: Sep 30
11/7
08:10 am
sava
Form 8-K CASSAVA SCIENCES INC For: Nov 07
Medium
Report
Form 8-K CASSAVA SCIENCES INC For: Nov 07
11/4
04:10 pm
sava
Form SC 13G/A CASSAVA SCIENCES INC Filed by: BARBIER REMI
Medium
Report
Form SC 13G/A CASSAVA SCIENCES INC Filed by: BARBIER REMI
10/8
08:11 am
sava
Form 8-K CASSAVA SCIENCES INC For: Oct 08
Low
Report
Form 8-K CASSAVA SCIENCES INC For: Oct 08
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/20
Form 4 CASSAVA SCIENCES INC For: Dec 20 Filed by: ROBERTSON SANFORD
60.3%
12/31 Form 4 CASSAVA SCIENCES INC For: Dec 31 Filed by: BARBIER REMI 37.1%
4/23 Cassava Sciences Announces New $2.5 Million Research Grant Award from National Institutes of Health 32.9%
12/26 Form 4/A CASSAVA SCIENCES INC For: Dec 18 Filed by: BARBIER REMI 29.3%
1/28 Cassava Sciences Announces Completion of Patient Enrollment of a Phase 2b Study in Alzheimer’s Disease 20.8%
9/3 Cassava Sciences to Present at H.C. Wainwright’s 21st Annual Global Investment Conference 17.9%
12/19 Form 4 CASSAVA SCIENCES INC For: Dec 19 Filed by: ROBERTSON SANFORD 17.5%
3/19 Cassava Sciences Announces Clinical Update and Business Progress Across Neuroscience Pipeline 17.2%
4/9 Form S-3/A CASSAVA SCIENCES INC 16.5%
1/15 Cassava Sciences Inc (NASDAQ: SAVA) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 14.5%
12/31 Form 4 CASSAVA SCIENCES INC For: Dec 31 Filed by: BARBIER REMI 37.1%
4/23 Cassava Sciences Announces New $2.5 Million Research Grant Award from National Institutes of Health 32.9%
12/26 Form 4/A CASSAVA SCIENCES INC For: Dec 18 Filed by: BARBIER REMI 29.3%
1/28 Cassava Sciences Announces Completion of Patient Enrollment of a Phase 2b Study in Alzheimer’s Disease 20.8%
9/3 Cassava Sciences to Present at H.C. Wainwright’s 21st Annual Global Investment Conference 17.9%
12/19 Form 4 CASSAVA SCIENCES INC For: Dec 19 Filed by: ROBERTSON SANFORD 17.5%
3/19 Cassava Sciences Announces Clinical Update and Business Progress Across Neuroscience Pipeline 17.2%
4/9 Form S-3/A CASSAVA SCIENCES INC 16.5%
1/15 Cassava Sciences Inc (NASDAQ: SAVA) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 14.5%
TOP News Decliners
12/6
Cassava Sciences Inc (NASDAQ: SAVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock, up previously from $3.00.
-21.8%
9/9 Cassava Sciences Reports Positive Phase 2a Clinical Results in Alzheimer’s Patients -15.9%
1/6 Are Insiders Buying Cassava Sciences, Inc. (NASDAQ:SAVA) Stock? [Yahoo! Finance News] -9.6%
1/7 Form SC 13G/A CASSAVA SCIENCES INC Filed by: HIRSCHMAN ORIN -9.4%
6/25 Cassava Sciences Inc (NASDAQ: SAVA) is now covered by analysts at Maxim Group. They set a "buy" rating on the stock. -8.5%
1/24 Cassava Sciences Inc (NASDAQ: SAVA) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock. -8.0%
8/1 Cassava Sciences Inc (NASDAQ: SAVA) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $3.00 price target on the stock. -7.6%
8/12 Q2/2019 6/30/2019 EPS -0.060 ZacksConsensus -0.120 ActVsEst 0.060 - Beat -6.8%
3/27 Form S-3 CASSAVA SCIENCES INC -5.2%
10/19 Cassava Sciences Inc (NASDAQ: SAVA) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -4.8%
9/9 Cassava Sciences Reports Positive Phase 2a Clinical Results in Alzheimer’s Patients -15.9%
1/6 Are Insiders Buying Cassava Sciences, Inc. (NASDAQ:SAVA) Stock? [Yahoo! Finance News] -9.6%
1/7 Form SC 13G/A CASSAVA SCIENCES INC Filed by: HIRSCHMAN ORIN -9.4%
6/25 Cassava Sciences Inc (NASDAQ: SAVA) is now covered by analysts at Maxim Group. They set a "buy" rating on the stock. -8.5%
1/24 Cassava Sciences Inc (NASDAQ: SAVA) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock. -8.0%
8/1 Cassava Sciences Inc (NASDAQ: SAVA) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $3.00 price target on the stock. -7.6%
8/12 Q2/2019 6/30/2019 EPS -0.060 ZacksConsensus -0.120 ActVsEst 0.060 - Beat -6.8%
3/27 Form S-3 CASSAVA SCIENCES INC -5.2%
10/19 Cassava Sciences Inc (NASDAQ: SAVA) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -4.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: